Denosumab Discontinuation

Presentations/Presenters

Denosumab Discontinuation
Presenter: Bente Langdahl, MD, PhD, DMSc (Aarhus University Hospital)
Relationship: Commercial Interest(s)
  Advisory Board Member: Amgen Inc
  Advisory Board Member: Other (fill in the blank below)
  Advisory Board Member: UCB, Gedeon-Richter
  Speaker: AstraZeneca
  Speaker: Other (fill in the blank below)
  Speaker: UCB, Gedeon-Richter, Astellas
  Grant Recipient: Amgen Inc
  Grant Recipient: Novo Nordisk

Summary

Availability:

On-Demand

Cost:

FREE

Credit Offered:

0.75 AMA PRA Category 1 Credit


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274